Citations (116)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
L.T. Clement. (1983) Purification and Characterization of Guinea PIG Anti Thrombin III. Preparative Biochemistry 13:1, pages 1-20.
Read now
Read now
L. Heck, R. Rosenberg & H. Remold. (1979) Purification and Properties of Guine Pig Antithrombin III. Preparative Biochemistry 9:4, pages 359-377.
Read now
Read now
H. Arnesen & M. K. Fagerhol. (1972) α2-Macroglobulin, α1-Antitrypsin, and Antithrombin III in Plasma and Serum during Fibrinolytic Therapy with Urokinase. Scandinavian Journal of Clinical and Laboratory Investigation 29:3, pages 259-263.
Read now
Read now
U. Abildgaard, M. K. Fagerhol & O. Egeberg. (1970) Comparison of Progressive Antithrombin Activity and the Concentrations of Three Thrombin Inhibitors in Human Plasma. Scandinavian Journal of Clinical and Laboratory Investigation 26:4, pages 349-354.
Read now
Read now
U. Abildgaard. (1969) Binding of Thrombin to Antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation 24:1, pages 23-27.
Read now
Read now
P. O. Ganrot. (1969) Electrophoretic Separation of Two Thrombin Inhibitors in Plasma and Serum. Scandinavian Journal of Clinical and Laboratory Investigation 24:1, pages 11-14.
Read now
Read now
U. Abildgaard. (1968) Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis. Scandinavian Journal of Clinical and Laboratory Investigation 21:1, pages 89-91.
Read now
Read now
U. Abildgaard. (1967) Inhibition of the Thrombin-fibrinogen Reaction by Antithrombin III, Studied by N-terminal Analysis. Scandinavian Journal of Clinical and Laboratory Investigation 20:3, pages 207-216.
Read now
Read now
Articles from other publishers (108)
Vignesh K. Manivasagam & Ketul C. Popat. (2020) In Vitro Investigation of Hemocompatibility of Hydrothermally Treated Titanium and Titanium Alloy Surfaces. ACS Omega 5:14, pages 8108-8120.
Crossref
Crossref
Leslie Roy Berry & Anthony Kam Chuen Chan. 2008. Biomaterials Fabrication and Processing Handbook. Biomaterials Fabrication and Processing Handbook
535
572
.
Rodger L. Bick & William F. Baker. 2010. Hematological Complications in Obstetrics, Pregnancy, and Gynecology. Hematological Complications in Obstetrics, Pregnancy, and Gynecology
122
199
.
J D Stamatakis, D Lawrence & V V Kakkar. (1977) Surgery, venous thrombosis and anti-Xa. British Journal of Surgery 64:10, pages 709-711.
Crossref
Crossref
Rodger L Bick. (2003) Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects. Hematology/Oncology Clinics of North America 17:1, pages 9-36.
Crossref
Crossref
Salvatore Innocente. 2000. Textbook of Angiology. Textbook of Angiology
501
507
.
Rodger L. Bick & Harold Kaplan. (1998) SYNDROMES OF THROMBOSIS AND HYPERCOAGULABILITY. Medical Clinics of North America 82:3, pages 409-458.
Crossref
Crossref
Rodger L. Bick & Harold Kaplan. (2016) Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias. Clinical and Applied Thrombosis/Hemostasis 4:1, pages 25-50.
Crossref
Crossref
L. Javelin. 1998. Antithrombin — Diagnostik und Therapie. Antithrombin — Diagnostik und Therapie
1
16
.
Rodger L. Bick & Dorota Ancypa. (1995) Blood Protein Defects Associated with Thrombosis: Laboratory Assessment. Clinics in Laboratory Medicine 15:1, pages 125-164.
Crossref
Crossref
H. Büntemeyer, H. Tebbe, D. Lütkemeyer & J. Lehmann. (1994) Rapid high-performance liquid chromatographic quantification of recombinant human antithrombin III during production and purification. Journal of Chromatography B: Biomedical Sciences and Applications 662:2, pages 209-216.
Crossref
Crossref
Rodger L. Bick. (1994) Hypercoagulability and thrombosis. Medical Clinics of North America 78:3, pages 635-665.
Crossref
Crossref
W. P. Sheffield, F. Fernandez-Rachubinski, R. C. Austin & M. A. Blajchman. 1991. Recombinant Technology in Hemostasis and Thrombosis. Recombinant Technology in Hemostasis and Thrombosis
133
146
.
Kazuyuki Shimada, Toshio Ozawa & Masashi Kobayashi. (2005) Human recombinant interleukin‐1β‐ and tumor necrosis factor α‐mediated suppression of heparin‐like compounds on cultured porcine aortic endothelial cells. Journal of Cellular Physiology 144:3, pages 383-390.
Crossref
Crossref
Travis J. Phifer & Glenn M. Mills. (1990) Occult antithrombin III deficiency: A potentially lethal complication of the postphlebitic limb. Journal of Vascular Surgery 11:4, pages 586-590.
Crossref
Crossref
P. Fuhge, P. Gratz & H. Geiger. (1990) Modern methods for the manufacture of coagulation factor concentrates. Transfusion Science 11, pages S23-S33.
Crossref
Crossref
W. Schramm, M. Spannagl & H. P. Schwarz. 1990. 20. Hämophilie-Symposion Hamburg 1989. 20. Hämophilie-Symposion Hamburg 1989
263
274
.
Angelina C.A. Carvalho, Sandra M. DeMarinis, Karen Lynch & Warren M. Zapol. (1989) Antithrombin III in critically ill patients. Journal of Critical Care 4:4, pages 283-293.
Crossref
Crossref
David L. Hoffman. (1989) Purification and large-scale preparation of antithrombin III. The American Journal of Medicine 87:3, pages S23-S26.
Crossref
Crossref
D. MICHAEL RITTER, CHARLES A. OWENJr.Jr., E.J. WALTER BOWIE, STEVEN R. RETTKE, THERESE L. COLE, HOWARD F. TASWELL, DUANE M. ILSTRUP, RUSSELL H. WIESNER & RUUD A.F. KROM. (1989) Evaluation of Preoperative Hematology-Coagulation Screening in Liver Transplantation. Mayo Clinic Proceedings 64:2, pages 216-223.
Crossref
Crossref
Richard S. Newman. (1987) Excessive Blood Loss and Its Relationship to Clotting System Changes During and After Major Surgery. Critical Care Clinics 3:2, pages 417-427.
Crossref
Crossref
Jack Hirsh, Russell D. Hull & Gary E. Raskob. (1986) Epidemiology and pathogenesis of venous thrombosis. Journal of the American College of Cardiology 8:6, pages 104B-113B.
Crossref
Crossref
D. Collen, H.R. Lijnen & Edward F. Plow. (1986) The fibrinolytic system in man. Critical Reviews in Oncology/Hematology 4:3, pages 249-301.
Crossref
Crossref
B. A. Kudrjashov & L. A. Lyapina. 1986. Thrombosis and Thrombolysis. Thrombosis and Thrombolysis
33
63
.
E.A.R. Knot, J.W. ten Cate, T. Bruin, A.H.C. Iburg & G.N.J. Tytgat. (1985) Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency. Gastroenterology 89:2, pages 421-425.
Crossref
Crossref
Ryoichi Yamagishi, Masahiro Niwa, Shin-ichi Kondo, Nobuo Sakuragawa & Takehiko Koide. (1984) Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Thrombosis Research 36:6, pages 633-642.
Crossref
Crossref
Bruce M. Rothschild. (1984) Role of antithrombin III in clinical management of pulmonary embolization. The American Journal of Medicine 77:2, pages A84-A86.
Crossref
Crossref
Laurence A. Sherman. (1984) 2 New Plasma Components. Clinics in Haematology 13:1, pages 17-38.
Crossref
Crossref
P. Lambin, F. Pochon & M. Steinbuch. 1984. Proteases. Proteases
263
272
.
Joyce E. Gardiner & John H. Griffin. 1984. Hemostatic Mechanisms and Metastasis. Hemostatic Mechanisms and Metastasis
39
55
.
E. B. Reeve, R. D. Bies, B. D. Leonard & A. Stephens. 1984. Pathophysiology of Plasma Protein Metabolism. Pathophysiology of Plasma Protein Metabolism
279
298
.
E. B. Reeve, R. D. Bies, B. D. Leonard & A. Stephens. 1984. Pathophysiology of Plasma Protein Metabolism. Pathophysiology of Plasma Protein Metabolism
279
298
.
G B Villanueva & N Allen. (1983) Refolding properties of antithrombin III. Mechanism of binding to heparin.. Journal of Biological Chemistry 258:22, pages 14048-14053.
Crossref
Crossref
T.M. Cosgriff, L.A. Hodgson & J.V. West. (2009)
The Antithrombin III Content of Cryoprecipitate Prepared from Blood Collected with and without Heparin
1
. Vox Sanguinis 44:2, pages 98-101.
Crossref
Crossref
Derek OgstonDerek Ogston. 1983. The Physiology of Hemostasis. The Physiology of Hemostasis
57
140
.
F. Pochon, P. Lambin & M. Steinbuch. (1982) Heparin and the progressive anti-thrombin activity of α2-macroglobulin. Thrombosis Research 26:5, pages 307-316.
Crossref
Crossref
D M Tollefsen, D W Majerus & M K Blank. (1982) Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.. Journal of Biological Chemistry 257:5, pages 2162-2169.
Crossref
Crossref
P. Wunderwald, W.J. Schrenk & H. Port. (1982) Antithrombin bm from human plasma: An antithrombin binding moderately to heparin. Thrombosis Research 25:3, pages 177-191.
Crossref
Crossref
I. Bj�rk & U. Lindahl. (1982) Mechanism of the anticoagulant action of heparin. Molecular and Cellular Biochemistry 48:3, pages 161-182.
Crossref
Crossref
H.T. Salem, M. Seppälä & T. Chard. (1981) The effect of thrombin on serum placental protein 5 (PP5): is PP5 the naturally occurring antithrombin III of the human placenta?. Placenta 2:3, pages 205-209.
Crossref
Crossref
George L. Dale & Beryl Westwood. (1981) Antithrombin III does not have bound glucocerebroside. Biochimica et Biophysica Acta (BBA) - Protein Structure 669:2, pages 260-262.
Crossref
Crossref
G.D.O. LOWE. (1981) Laboratory Evaluation of Hypercoagulability. Clinics in Haematology 10:2, pages 407-442.
Crossref
Crossref
E. THALER & K. LECHNER. (1981) Antithrombin III Deficiency and Thromboembolism. Clinics in Haematology 10:2, pages 369-390.
Crossref
Crossref
P. Andersen, P. Kierulf & H.C. Godal. (1981) The antiheparin effect of α1-acid glycoprotein: Influence on heparin tolerance during the acute phase reaction. Thrombosis Research 22:5-6, pages 593-602.
Crossref
Crossref
Byung K. Kim, Manfred Steiner & Mario G. Baldini. (1980) Antithrombin III binds to human platelets. Biochemical and Biophysical Research Communications 97:3, pages 1227-1232.
Crossref
Crossref
J. MONASTERIO, J. JUNCÁ, J. TORRAS, B. CLOTET, M. CERVANTES, J.L. ALLOZA & J. TRIGINER. (1980) Antithrombin III contribution to cholestasis differential diagnosis: its correlation with one stage prothrombin time and factor V. Clinical & Laboratory Haematology 2:3, pages 185-190.
Crossref
Crossref
Ø. Grimmer, L. Aukrust & P. Andersen. (1980) Crossed radioimmunoelectrophoresis in the study of thrombin-binding proteins in human plasma. Thrombosis Research 19:3, pages 393-400.
Crossref
Crossref
German B. Villanueva, Vera Perret & Isidore Danishefsky. (1980) Tryptophan residue at the heparin binding site in antithrombin III. Archives of Biochemistry and Biophysics 203:1, pages 453-457.
Crossref
Crossref
E. Holmer, U. Lindahl, G. Bäckström, L. Thunberg, H. Sandberg, G. Söderström & L.-O. Andersson. (1980) Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thrombosis Research 18:6, pages 861-869.
Crossref
Crossref
E. Holmer, G. Söderström & L.-O. Andersson. (1980) Properties of antithrombin III depleted plasma I. Effect of heparin. Thrombosis Research 17:1-2, pages 113-124.
Crossref
Crossref
R A Jimenez, E Jimenez, G I Ingram, L A Mora, F Atmetlla, J M Carrillo & W Vargas. (1979) Antithrombin activities in childhood malnutrition.. Journal of Clinical Pathology 32:10, pages 1025-1029.
Crossref
Crossref
P. D. Mintz, P. M. Blatt, W. J. Kuhns & H. R. Roberts. (2003) Antithrombin III in Fresh Frozen Plasma, Cryoprecipitate, and Cryoprecipitate‐depleted Plasma. Transfusion 19:5, pages 597-598.
Crossref
Crossref
M. Wickerhauser, C. Williams & J. Mercer. (2009) Development of Large Scale Fractionation Methods. Vox Sanguinis 36:5, pages 281-293.
Crossref
Crossref
Vivian Chan, T.K. Chan, Vivian Wong, S. C. Tso & D. Todd. (2008) The Determination of Antithrombin III by Radioimmunoassay and its Clinical Application. British Journal of Haematology 41:4, pages 563-572.
Crossref
Crossref
Vivian Chan & T.K. Chan. (1979) Antithrombin III in fresh and cultured human endothelial cells: A natural anticoagulant from the vascular endothelium. Thrombosis Research 15:1-2, pages 209-213.
Crossref
Crossref
M.L. Zucker, E.D. Gomperts, D. Russel, B. Joffe, M. Feesey, R. Kuschke & H. Seftel. (1979) Antithrombin functional activity after saturated and unsaturated fatty meals and fasting in normal subjects and some disease states. Thrombosis Research 15:1-2, pages 37-48.
Crossref
Crossref
Anthony K.Y. Lee, Vivian Chan & T.K. Chan. (1979) The identification and localization of antithrombin III in human tissues. Thrombosis Research 14:1, pages 209-217.
Crossref
Crossref
V.V Kakkar, D Lawrence, P.G Bentley, H.A de Haas, Valerie P Ward & M.F Scully. (1978) A comparative study of low doses of heparin and a heparin analogue in the prevention of postoperative deep vein thrombosis. Thrombosis Research 13:1, pages 111-122.
Crossref
Crossref
L.H. Kahlé, H.G. Schipper, C.S.P. Jenkins & J.W. ten Cate. (1978) Antithrombin III I. Evaluation of an automated antithrombin III method. Thrombosis Research 12:6, pages 1003-1014.
Crossref
Crossref
HansG Schipper, LaurensH Kahlé, CharlesS.P Jenkins & JAN.W.TEN Cate. (1978) ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATION. The Lancet 311:8069, pages 854-856.
Crossref
Crossref
C. Vermeer, B.A.M. Soute & H.C. Hemker. (1978) Improvements of the method for the preparation of an artificial prothrombin reagent. Thrombosis Research 12:4, pages 713-716.
Crossref
Crossref
Milka M. Montiel & David L. McGlasson. (1978) Antithrombin III activity in baboons. Primates 19:2, pages 371-378.
Crossref
Crossref
I. Danishefsky, A. Zweben & B.L. Slomiany. (1978) Human antithrombin III. Carbohydrate components and associated glycolipid.. Journal of Biological Chemistry 253:1, pages 32-37.
Crossref
Crossref
N. KOBAYASHI & Y. TAKEDA. (2008) Effects of a large dose of oestradiol on antithrombin III metabolism in male and female dogs. European Journal of Clinical Investigation 7:5, pages 373-381.
Crossref
Crossref
O.R. Ødegård, U. Abildgaard, M. Lie & M. Miller-Andersson. (1977) Inactivation of bovine and human thrombin and factor Xa by antithrombin III studied with amidolytic methods. Thrombosis Research 11:2, pages 205-216.
Crossref
Crossref
H. Suomela, G. Myllylä & E. Raaska. (2009) Preparation and Properties of a Therapeutic Factor IX Concentrate. Vox Sanguinis 33:1, pages 37-50.
Crossref
Crossref
I. Danishefsky, M. Ahrens & S. Klein. (1977) Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III. Biochimica et Biophysica Acta (BBA) - General Subjects 498:1, pages 215-222.
Crossref
Crossref
K. Heide, H. Haupt & H.G. Schwick. 1977. The Plasma Proteins. The Plasma Proteins
545
597
.
Shirley P. Levine, Herbert Wohl, Ulla Marzec, Eugene F. Bernstein & Joan Kroener. (1977) Release of platelet factor 4 (PF4) measured by a polybrene® assay in response to in vitro platelet damage. Thrombosis Research 10:1, pages 1-10.
Crossref
Crossref
D. Ogston, J. Murray & G.P.M. Crawford. (1976) Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin. Thrombosis Research 9:3, pages 217-222.
Crossref
Crossref
I. Danishefsky, F. Tzeng, M. Ahrens & S. Klein. (1976) Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor. Thrombosis Research 8:2, pages 131-140.
Crossref
Crossref
Paul S. Damus & Robert D. Rosenberg. 1976. Part B: Proteolytic Enzymes. Part B: Proteolytic Enzymes
653
669
.
L.A. Learned, J.W. Bloom & M.J. Hunter. (1976) The antithrombin activity of α-I-protease inhibitor: The antitrypsin activity of antithrombin III. Thrombosis Research 8:1, pages 99-109.
Crossref
Crossref
P. J. Grob. 1976. Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics
95
199
.
Philip Davies. 1976. Structure and Function of Plasma Proteins. Structure and Function of Plasma Proteins
189
238
.
Allen P. Kaplan & K.F. Austen. (1975) Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response. Journal of Allergy and Clinical Immunology 56:6, pages 491-506.
Crossref
Crossref
E. Thaler & G. Schmer. (2008) A Simple Two‐step Isolation Procedure for Human and Bovine Antithrombin II/III (Heparin Cofactor): a Comparison of Two Methods. British Journal of Haematology 31:2, pages 233-243.
Crossref
Crossref
O.R. Ødegård. (1975) Evaluation of an amidolytic heparin cofactor assay method. Thrombosis Research 7:2, pages 351-360.
Crossref
Crossref
Sanford N Gitel & Stanford Wessler. (1975) Plasma antithrombin III: A quantitative assay of biological activity. Thrombosis Research 7:1, pages 5-16.
Crossref
Crossref
Janet L. Lane, Prudence Bird & C. R. Rizza. (2008) A New Assay for the Measurement of Total Progressive Antithrombin. British Journal of Haematology 30:1, pages 103-115.
Crossref
Crossref
George P.M. Crawford & Derek Ogston. (1975) The action of antithrombin III on plasmin and activators of plasminogen. Biochimica et Biophysica Acta (BBA) - Enzymology 391:1, pages 189-192.
Crossref
Crossref
O.R Ødegård, M Lie & U Abildgaard. (1975) Heparin cofactor activity measured with an amidolytic method. Thrombosis Research 6:4, pages 287-294.
Crossref
Crossref
Frank W. Putnam. 1975. The Plasma Proteins. The Plasma Proteins
57
131
.
N. Heimburger. 1975. Lung Metabolism. Lung Metabolism
3
24
.
C.-B. LAURELL. 1975. Protides of the Biological Fluids. Protides of the Biological Fluids
3
12
.
Anna D. Borsodi, Ralph A. Bradshaw, Indulal K. Rughani & Robert M. Bruce. 1975. Heparin. Heparin
249
253
.
H.C. Godal, M. Rygh & K. Laake. (1974) Progressive inactivation of purified factor VII by heparin and antithrombin III. Thrombosis Research 5:6, pages 773-775.
Crossref
Crossref
OSCAR D. RATNOFF. (1974) Brief Reviews: Some Recent Advances in the Study of Hemostasis. Circulation Research 35:1, pages 1-14.
Crossref
Crossref
George F. Briginshaw & J.N. Shanberge. (1974) Identification of two distinct heparin cofactors in human plasma. Archives of Biochemistry and Biophysics 161:2, pages 683-690.
Crossref
Crossref
J. Hirsh & E. Genton. 1974. Blood. Blood
99
133
.
Oscar D. Ratnoff. 1974. Blood. Blood
3
50
.
Ulla Hedner & Inga Marie Nilsson. (1973) Antithrombin III in a clinical material. Thrombosis Research 3:6, pages 631-641.
Crossref
Crossref
Robert D. Rosenberg & Paul S. Damus. (1973) The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor. Journal of Biological Chemistry 248:18, pages 6490-6505.
Crossref
Crossref
E. Jakobsen & P. Kierulf. (1973) A modified beta-alanine precipitation procedure to prepare fibrinogen free of antithrombin-III and plasminogen. Thrombosis Research 3:2, pages 145-159.
Crossref
Crossref
F. Markwardt, J. Hoffmann & E. Körbs. (1973) The influence of synthetic thrombin inhibitors on the thrombin-antithrombin reaction. Thrombosis Research 2:4, pages 343-348.
Crossref
Crossref
H.C. Godal, C. Eika & P. Kierulf. (1973) Liquoid, a weak anticoagulant with strong “procoagulant” properties as compared with heparin. Thrombosis Research 2:2, pages 155-171.
Crossref
Crossref
P. A. Owren & H. Stormorken. 1973. Ergebnisse der Physiologie Reviews of Physiology, Volume 68. Ergebnisse der Physiologie Reviews of Physiology, Volume 68
1
53
.
H. RINDERKNECHT & M. C. GEOKAS. (1972) Role for a2-Macroglobulin in Haemostatic Balance. Nature New Biology 239:91, pages 116-117.
Crossref
Crossref
Ewa Marciniak & Sumiko Tsukamura. (2008) Two Progressive Inhibitors of Factor Xa in Human Blood. British Journal of Haematology 22:3, pages 341-351.
Crossref
Crossref
H.E. Rugstad, H. Prydz & Birgitta Johansson. (1972) Synthesis of coagulation factors by a clonal strain of rat hepatoma cells. Experimental Cell Research 71:1, pages 41-44.
Crossref
Crossref
C. Eika. (2009) Inhibition of Thrombin‐Induced Aggregation of Human Platelets by Heparin and Antithrombin III. Scandinavian Journal of Haematology 8:4, pages 250-256.
Crossref
Crossref
C. Eika. (2009) Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin. Scandinavian Journal of Haematology 8:3, pages 216-222.
Crossref
Crossref
M. Steinbuch. (1971) Les antiprotéases du plasma. Revue Française de Transfusion 14:1, pages 61-82.
Crossref
Crossref
W. R. Pitney & E. Regoeczi. (2008) Inactivation of ‘Arvin’ by Plasma Proteins. British Journal of Haematology 19:1, pages 67-81.
Crossref
Crossref
Lewis T. MannJr.Jr., Jens Chr. Jensenius, Morten Simonsen & Ulrich Abildgaard. (1969) Antithrombin III: Protection against Death after Injection of Thromboplastin. Science 166:3904, pages 517-518.
Crossref
Crossref
U. Abildgaard. (2009) Inhibition of the Thrombin‐Fibrinogen Reaction by Heparin and Purified Cofactor. Scandinavian Journal of Haematology 5:6, pages 440-453.
Crossref
Crossref
U. Abildgaard. (2009) Inhibition of the Thrombin‐Fibrinogen Reaction by Heparin in the Absence of Cofactor. Scandinavian Journal of Haematology 5:6, pages 432-439.
Crossref
Crossref
U. ABILDGAARD & O. EGEBERG. (2009) Thrombin Inhibitory Activity of Fractions Obtained by Gel Filtration of Antithrombin III Deficient Plasma. Scandinavian Journal of Haematology 5:2, pages 155-157.
Crossref
Crossref